Brief report · 30 Jun 2026
Conference abstractPublished 8 Dec 2014
New agonists of the CB2 cannabinoid receptor: Discovery of a new class of analgesic compounds
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Interest in the potential medicinal use of cannabinoids grew recently with the discovery of 2 cannabinoid receptors, CB1 and CB2. The CB1 receptor is abundantly expressed in the central nervous system (CNS) and is responsible for the psychotropic side effects. The CB2 receptor is mainly found in cells of the immune system, though it may be upregulated in the CNS under pathological conditions. The main signal transduction pathway triggered is through Gi proteins, resulting in an inhibition of adenylate cylase activity and a decrease in cyclic AMP levels. Recent developments indicate that CB2 receptor ligands have the potential to become therapeutically important. To explore this potential, it is necessary to develop compounds with high affinity for the CB2 receptor. Within a research program to identify novel CB2 agonists, our group designed a hybrid chemical structure that incorporated the structural features of known cannabinoid ligands. The new series of oxazinoquinolone derivatives exhibiting high affinity and selectivity for the CB2 receptor (hCB2 Ki=8.12 nM, hCB1 Ki>10000, selectivity index (SI)>1231). The potency of the new oxazinoquinoline-6-carboxamides was measured in functional assays, revealing that the novel series behaved as CB2 receptor full agonists. The effect of a novel CB2 agonist (MT178) was evaluated in different animal models of pain. In this context, very recently, we have also reported the medicinal chemistry of a series of heteroaryl-4-oxopyridine/7- oxo-pyrimidine derivative which displayed high affinity at the CB2 receptor (hCB2 Ki=11.4 nM, hCB1 Ki=4568, SI=401). In this study, additional CB2 ligands were synthesized by replacing the pyrazolo ring with different heterocycles that were found to be potent CB2 receptor ligands. Moreover, it was shown that the functionality of these ligands is controlled by the nature of the heteroaryl function condensed with the pyridine ring. In 3, 5-cyclic adenosine monophosphate (cAMP) assays, they showed a dose-dependent effect in the modulation of forskolin-induced cAMP production, revealing different behaviors as full agonists, partial agonists and inverse agonists. Finally, we synthesized the structural isomers of our previously reported pyrazolo[3, 4-b]pyridines that allowed us to conduct a pharmacophore exploration and optimization effort around the heteroaryl central scaffold. The newly synthesized 7-oxo-pyrazolo[1, 5-a]pyrimidine-6-carboxamides were tested in competition binding assays toward both rat CB1 and CB2 receptors expressed in native tissues (rat brain or spleen) and human CB1 and CB2 receptors expressed in CHO cells. Affinity data (Ki, nM) were used to calculate the selectivity of newly synthesized compounds for the CB2 receptors. All of the new compounds showed high affinity and selectivity for the CB2 receptor in the nanomolar range. In 3, 5-cyclic adenosine monophosphate (cAMP) assays, the novel series shows stimulatory effects on forskolin-induced cAMP production acting as inverse agonists.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pier Giovanni Baraldi”
- BylineArticles whose byline prints “Giulia Saponaro”
- BylineArticles whose byline prints “Romeo Romagnoli”
- BylineArticles whose byline prints “Delia Preti”
- BylineArticles whose byline prints “Stefania Baraldi”
- BylineArticles whose byline prints “Katia Varani”
- BylineArticles whose byline prints “Pier Andrea Borea”
- BylineArticles whose byline prints “Mojgan Aghazadeh Tabrizi”
